Product

Company

NCT01795352·12 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Observational retrospective study to describe the management of advanced or metastatic EGFR mutated non-small cell lung cancer patients in Spain

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Histologically or cytologically confirmed newly locally advanced or metastatic NSCLC (stage IIIB/IV)
Confirmed EGFR mutation by a validated test
Availability of medical record

Participating on a blinded randomized clinical trial at any time during the study period
Pregnant women (due to they do not reflect daily clinical practice)

The record

StatusCompleted

PhaseNo phase

Taking part187

StartedMar 2013

UpdatedOct 30, 2013

Conditions

Where12

Clareo Health | Retrospective Study in a NSCLC M+ p